1 in 9 persons tested found positive for infectious disease in ICMR study

New Delhi: Pathogens were found in 11.1 % of the 4.5 lakh patients tested by the network of labs under the Indian Council of Medical Research as part of efforts to identify viral infections of public health significance.

The top five pathogens detected were Influenza A in acute respiratory infection (ARI)/ severe acute respiratory infections (SARI cases), dengue virus among acute fever and haemorrhagic fever cases, Hepatitis A in jaundice cases, Norovirus in among acute diarrhoeal disease (ADD) outbreaks and Herpes simplex virus (HSV) in Acute Encephalitis Syndrome (AES) cases.

The spread of infectious diseases rose from 10.7 % in the first quarter to 11.5 % in the second quarter of 2025, according to the report by the Indian Council of Medical Research (ICMR). According to the Virus Research and Diagnostic Laboratories (VRDL) network of ICMR, between January and March, out of 2,28,856 samples, 24,502 (10.7 %) were found to contain pathogens from April to June 2025, 26,055 (11.5 %) out of 2,26,095 samples tested positive. Thus, the infection rate rose by 0.8 percentage points over the previous quarter, signalling the need for stronger monitoring of infection trends.

According to a senior scientist while this increase may not appear large, it should not be underestimated – it could serve as a warning for seasonal diseases and emerging infections.

If we continue tracking quarterly changes in infection rates, future epidemics could be prevented in time. The VRDL network acts as an early warning system for the country.

The ICMR report found that between April and June this year, 191 disease cluster were investigated and infectious diseases such as mumps, measles, rubella, dengue, chikungunya, rotavirus, norovirus, varicella zoster virus, Epstein-Barr virus (EBV) and astrovirus were identified.

Between January and March, 389 disease clusters were investigated and infectious diseases such as mumps, measles, rubella, hepatitis, dengue, chikungunya, rotavirus, influenza, Leptospira, Varicella zoster virus and Sexually transmitted infections (STIs) were identified.

From 2014-2024, more than 40 lakh samples were tested with pathogen identified in 18.8 %.

The VRDLN expanded from 27 laboratories in 2014 to 165 laboratories across 31 states and UTs by 2025. Through this network, 2,534 disease clusters have been identified across the country so far.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit